CBO Says Pay To Delay Bill Can Save $4.8 Billion

November 9, 2011
Pharmalot
By Ed Silverman

A bipartisan bill that would limit pay-to-delay settlements, which are designed to keep lower-cost generic drugs off the market for extended periods, would save taxpayers an estimated $4.8 billion over the next decade, according to a new report from the Congressional Budget Office. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story.